Oncology On The Go
By CancerNetwork
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by CancerNetwork
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 10
Reviews: 0
Episodes: 261
Description
Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences.
As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
To learn more, you can also visit us on Facebook, Twitter, and LinkedIn!
As the home of the journal ONCOLOGY, CancerNetwork offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.
To learn more, you can also visit us on Facebook, Twitter, and LinkedIn!
| Episode | Date |
|---|---|
|
S1 Ep235: How Oncologists Can Navigate Patient Requests for Medical Aid in Dying
|
Sep 28, 2026 |
|
S1 Ep234: What Were the Key Hematologic Oncology Takeaways from SOHO 2026?
|
Sep 21, 2026 |
|
S1 Ep233: Rethinking BCG Failure and The Bladder-Sparing Boom in NMIBC
|
Sep 14, 2026 |
|
S1 Ep232: Unpacking Iberdomide’s FDA Approval and The Future of CELMoDs
|
Sep 07, 2026 |
|
S1 Ep231: How Mentorship and Peer Support Help Oncologists Avoid Burnout
|
Aug 31, 2026 |
|
S1 Ep230: How Will Successfully Targeting KRAS Change Pancreatic Cancer Treatment?
|
Aug 24, 2026 |
|
S1 Ep229: How to Treat Depression in Patients With Cancer: A Practical Framework
|
Aug 17, 2026 |
|
S1 Ep228: Exploring CAR-T Updates in Pediatric Acute Lymphoblastic Leukemia
|
Aug 10, 2026 |
|
S1 Ep227: What Does Practical CAR T Cell Use Look Like in Multiple Myeloma Care?
|
Jul 31, 2026 |
|
S1 Ep226: Unraveling Immune Effector Therapy Advances Across Hematologic Oncology
|
Jul 27, 2026 |
|
S1 Ep225: How Will Orca-T Impact the Hematologic Oncology Paradigm?
|
Jul 20, 2026 |
|
S1 Ep224: Managing Insomnia in Cancer Care: Sleep Hygiene, CBT-I, and Medications
|
Jul 13, 2026 |
|
S1 Ep222: How Does a Death Doula Support Patients With Cancer?
|
Jul 06, 2026 |
|
S1 Ep223: Optimizing Frontline Selection and Treatment-Free Remission in CML
|
Jul 01, 2026 |
|
S1 Ep221: Redefining Lymphoma Standards of Care: Top Datasets From ASCO and EHA 2026
|
Jun 29, 2026 |
|
S1 Ep220: Exploring The Future of Artificial Intelligence and Thoracic Oncology
|
Jun 22, 2026 |
|
S1 Ep219: Navigating Personality Disorders in Cancer Care
|
Jun 15, 2026 |
|
S1 Ep218: Unraveling Key Hematologic Oncology Developments at ASCO 2026
|
Jun 08, 2026 |
|
S1 Ep217: Integrating Exercise and Lifestyle Intervention Into Oncologic Therapy
|
Jun 01, 2026 |
|
S1 Ep216: How the Landscape of GI Oncology is Evolving | A 2026 ASCO Preview
|
May 28, 2026 |
|
S1 Ep215: Navigating The Dynamic Landscape of Stem Cell Transplantation
|
May 25, 2026 |
|
S1 Ep214: Are Zedoresertib and Lunresertib an Efficacious Combo Across Solid Tumors?
|
May 18, 2026 |
|
S1 Ep213: What Does the Future Hold for Immune Effector Cell Therapies?
|
May 11, 2026 |
|
S1 Ep212: Unraveling Daraxonrasib’s Breakthrough in Metastatic Pancreatic Cancer
|
May 04, 2026 |
|
S1 Ep211: Exploring and Managing Gastrointestinal-Related CAR T-Cell Lymphomas
|
Apr 27, 2026 |
|
S1 Ep210: Elevating Precision Medicine Across Different Oncologic Populations
|
Apr 20, 2026 |
|
S1 Ep209: Rising Incidence, Trial Enrollment, and Other Key Breast Cancer Challenges
|
Apr 13, 2026 |
|
S1 Ep208: Cancer and Suicide: Identifying Risk Factors and Providing Support
|
Apr 06, 2026 |
|
S1 Ep207: Providing Support for Mental Health Disorders Across Cancer Populations
|
Mar 30, 2026 |
|
S1 Ep206: Is It Helping or Harming? A Clinician’s Guide to Cannabis Use in Oncology
|
Mar 23, 2026 |
|
S1 Ep205: Insights Across Hematologic Oncology at Columbia University
|
Mar 16, 2026 |
|
S1 Ep204: Unraveling the Potential of Iberdomide and CELMoDs in Multiple Myeloma
|
Mar 09, 2026 |
|
S1 Ep203: Navigating Depression in Cancer Care
|
Mar 02, 2026 |
|
S1 Ep202: From Cold to Hot: Navigating a New Frontier of Breast Cancer Immunotherapy
|
Feb 23, 2026 |
|
S1 Ep201: What Were the Key Abstracts and Presentations at The 2026 Tandem Meetings?
|
Feb 16, 2026 |
|
S1 Ep200: Exploring the Bone Marrow Microenvironment’s Influence on NDMM Trajectory
|
Feb 09, 2026 |
|
S1 Ep199: How to Responsibly Use AI in Palliative Care and Hematologic Malignancies
|
Feb 02, 2026 |
|
S1 Ep198: Innovation, Elevation, and Empowerment Through Integrative Care in Oncology
|
Jan 26, 2026 |
|
S1 Ep197: How Can Bioimpedance Spectroscopy Help Detect Lymphedema Quicker?
|
Jan 19, 2026 |
|
S1 Ep196: Bolstering Outcomes and Building Bridges in Integrative Oncology Care
|
Jan 12, 2026 |
|
S1 Ep195: Advancing Research and Combatting Disparities in Pancreatic Cancer Care
|
Jan 05, 2026 |
|
S1 Ep194: What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting
|
Dec 29, 2025 |
|
S1 Ep193: Distress Screening: Making the Fifth Vital Sign Integral to Oncology Care
|
Dec 22, 2025 |
|
S1 Ep192: ASH 2025: Key Discussions in Multiple Myeloma, Lymphoma, and Leukemia
|
Dec 15, 2025 |
|
S1 Ep191: Why Sexual and Gender Minority Care is an Oncologic Imperative
|
Dec 08, 2025 |
|
S1 Ep190: Evolutions Across NSCLC, Multiple Myeloma, and AML at Georgia Cancer Center
|
Dec 01, 2025 |
|
S1 Ep189: Decision-Making Capacity: The Ethical Core of Patient-Centered Oncology
|
Nov 24, 2025 |
|
S1 Ep188: How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?
|
Nov 17, 2025 |
|
S1 Ep187: How Supportive Care Methods Can Improve Oncology Outcomes
|
Nov 10, 2025 |
|
S1 Ep186: How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
|
Nov 03, 2025 |
|
S1 Ep185: What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
|
Oct 27, 2025 |
|
S1 Ep184: Leveraging Biology to Advance the Small Cell Lung Cancer Treatment Paradigm
|
Oct 20, 2025 |
|
S1 Ep183: Charting the Evolution of TKIs and Finding the Next Breakthrough in CML
|
Oct 13, 2025 |
|
S1 Ep182: Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid Tumors
|
Oct 06, 2025 |
|
S1 Ep181: Gemcitabine Intravesical System Offers Tremendous Benefits in NMIBC
|
Sep 29, 2025 |
|
S1 Ep180: How To Discuss Death? A Conversation of Mortality in Cancer Care
|
Sep 22, 2025 |
|
S1 Ep179: Unraveling Key Blood Cancer Takeaways From the 2025 SOHO Meeting
|
Sep 15, 2025 |
|
S1 Ep178: Cardiovascular Considerations in Breast Cancer Treatment and Survivorship
|
Sep 08, 2025 |
|
S1 Ep177: Man Up? The Truth About Men's Health After Cancer
|
Sep 01, 2025 |
|
S1 Ep176: START Center Aims to Bring New Cancer Treatments, Trials to The Community
|
Aug 25, 2025 |
|
S1 Ep175: Beyond the Tumor: Addressing Body Image in Oncology
|
Aug 18, 2025 |
|
S1 Ep174: Navigating AE Management for Cellular Therapy Across Hematologic Cancers
|
Aug 11, 2025 |
|
S1 Ep173: Integrating Dato-DXd Into Early-Line EGFR-Mutant NSCLC Management
|
Aug 04, 2025 |
|
S1 Ep172: Key Advances Across Kidney Cancer Research and Management at KCRS 2025
|
Jul 28, 2025 |
|
S1 Ep171: Advancements and Evolving Strategies in Breast Cancer Treatment at IBC East
|
Jul 21, 2025 |
|
S1 Ep170: Taletrectinib Approval Expands Options in Advanced/Metastatic ROS1+ NSCLC
|
Jul 14, 2025 |
|
S1 Ep169: Best Practices for the Medical Oncology Boards
|
Jul 07, 2025 |
|
S1 Ep168: Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis
|
Jun 30, 2025 |
|
S1 Ep167: Practice-Changing Lung Cancer Data From The 2025 ASCO Annual Meeting
|
Jun 23, 2025 |
|
S1 Ep166: Adopting Best Practices for Administering TROP2-Directed ADCs in NSCLC
|
Jun 16, 2025 |
|
S1 Ep165: CAR T and Transplantation Advances Across Hematologic Cancers at ASCO 2025
|
Jun 09, 2025 |
|
S1 Ep164: Exploring Burnout Causes and Management in Oncologic Practice
|
Jun 02, 2025 |
|
S1 Ep163: Spotlighting Key Upcoming Presentations Across Oncology at ASCO 2025
|
May 26, 2025 |
|
S1 Ep162: Leveraging Artificial Intelligence to Bolster Equitable Cancer Care
|
May 19, 2025 |
|
S1 Ep161: Highlighting Advancements in Personalized T-Cell Lymphoma Treatment
|
May 12, 2025 |
|
S1 Ep160: Reviewing Real-World Use of Beti-Cel in Transfusion-Dependent β-Thalassemia
|
May 05, 2025 |
|
S1 Ep159: Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors
|
Apr 28, 2025 |
|
S1 Ep158: Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care
|
Apr 21, 2025 |
|
S1 Ep157: Fostering The Future of Psychosocial Care With World Psycho-Oncology Day
|
Apr 14, 2025 |
|
S1 Ep156: Elevating the Quality of Cancer Care Via Cross-Department Collaboration
|
Apr 07, 2025 |
|
S1 Ep155: Improving NSCLC Surgery Recovery After Climate Disaster Exposure
|
Mar 31, 2025 |
|
S1 Ep154: Considering Dosing and AE Management Strategies With Tarlatamab in SCLC
|
Mar 24, 2025 |
|
S1 Ep153: Redefining the Treatment Paradigm in Low Grade Serous Ovarian Cancer
|
Mar 17, 2025 |
|
S1 Ep152: Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care
|
Mar 10, 2025 |
|
S1 Ep151: Key CAR T and Transplantation Presentations From The 2025 Tandem Meeting
|
Mar 03, 2025 |
|
S1 Ep150: Sotorasib Combo Approval May Address Novel Therapy Need in KRAS G12C+ CRC
|
Feb 24, 2025 |
|
S1 Ep149: Highlighting Insights From the Marginal Zone Lymphoma Workshop
|
Feb 17, 2025 |
|
S1 Ep148: Navigating Management and Dosing Considerations for Amivantamab in NSCLC
|
Feb 10, 2025 |
|
S1 Ep147: Expanding and Advancing the Future of Renal Cell Carcinoma Treatment
|
Feb 03, 2025 |
|
S1 Ep146: Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology
|
Jan 27, 2025 |
|
S1 Ep145: Psilocybin May Help Address Cancer-Related Psychological Concerns
|
Jan 20, 2025 |
|
S1 Ep144: SABCS 2024 Data Show ‘Great Steps Forward’ in Breast Cancer Care
|
Jan 13, 2025 |
|
S1 Ep143: Using Multidisciplinary Lifestyle Medicine to Enhance Cancer Survivor QOL
|
Jan 06, 2025 |
|
S1 Ep142: Determining Suitable Radioligand Therapy Use in Neuroendocrine Tumors
|
Dec 30, 2024 |
|
S1 Ep141: Reducing Post-Mastectomy Disparities in Breast Cancer Minority Populations
|
Dec 23, 2024 |
|
S1 Ep140: Highlighting Advocacy Impacts on Funding for Kidney Cancer Research
|
Dec 16, 2024 |
|
S1 Ep139: Ensuring Holistic, Individualized Transitions of Care for Cancer Survivors
|
Dec 09, 2024 |
|
S1 Ep138: Managing Risks, Planning Treatment, & Making Progress in Pancreatic Cancer
|
Dec 02, 2024 |
|
S1 Ep137: Advancing Research and Targeting Genomic Alterations in Pancreatic Cancer
|
Nov 25, 2024 |
|
S1 Ep136: Collaboration Fosters Treatment Advancements for Young Lymphoma Populations
|
Nov 18, 2024 |
|
S1 Ep135: Educating Patients and Clinicians on End-of-Life Care and Discussions
|
Nov 11, 2024 |
|
S1 Ep134: Uterine Transposition May Maintain Fertility Following Pelvic Radiotherapy
|
Nov 04, 2024 |
|
S1 Ep133: Empowering Awareness to Address Rising Gynecological Cancer Incidence
|
Oct 28, 2024 |
|
S1 Ep132: Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases
|
Oct 21, 2024 |
|
S1 Ep131: Mitigating AEs and Protecting QOL Following Talquetamab in Multiple Myeloma
|
Oct 14, 2024 |
|
S1 Ep130: Forming Connections and Making a Difference in the Brain Cancer Field
|
Oct 07, 2024 |
|
S1 Ep129: Exploring the Potential Role of JAK Inhibitors in Multiple Myeloma
|
Sep 30, 2024 |
|
S1 Ep128: Advancing Glioblastoma Research Through a Phase 3 Niraparib Trial
|
Sep 23, 2024 |
|
S1 Ep127: Exploring the Value of Preoperative CAPTEM in Atypical Lung NETs
|
Sep 16, 2024 |
|
S1 Ep126: Improving Quality of Life in Cancer With Physical Medicine & Rehabilitation
|
Sep 09, 2024 |
|
S1 Ep125: Managing Secondary Cancer Risks After CAR T-Cell Therapy in Multiple Myeloma Subgroups
|
Sep 02, 2024 |
|
S1 Ep124: Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
|
Aug 26, 2024 |
|
S1 Ep123: Optimizing Benefits Following Dostarlimab Approval in Endometrial Cancer
|
Aug 19, 2024 |
|
S1 Ep122: Taking a “Cross-Cutting Approach” With Cancer Vaccinations
|
Aug 12, 2024 |
|
S1 Ep121: Advancing Pancreatic Cancer Care Through Intraoperative Radiation Therapy
|
Aug 05, 2024 |
|
S1 Ep120: Improving CAR T-Cell Therapy Monitoring Strategies and Access in Lymphoma
|
Jul 29, 2024 |
|
S1 Ep119: Exploring New Possibilities in Kidney Cancer Detection and Therapy
|
Jul 22, 2024 |
|
S1 Ep118: Overcoming Physical and Social Barriers in the Lymphoma Field
|
Jul 15, 2024 |
|
S1 Ep117: Epcoritamab Approval Expands Bispecific Use in Follicular Lymphoma
|
Jul 08, 2024 |
|
S1 Ep116: Leveraging Artificial Intelligence Evolutions in Prostate Cancer Care
|
Jul 01, 2024 |
|
S1 Ep115: Ensuring Quality Outcomes in Hematologic Cancer Subgroups at EHA 2024
|
Jun 24, 2024 |
|
S1 Ep114: Applying Updated Breast Cancer Findings From ASCO to Clinical Practice
|
Jun 17, 2024 |
|
S1 Ep113: Optimizing Metastatic CRC Outcomes Following Fruquintinib Approval
|
Jun 10, 2024 |
|
S1 Ep112: Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology
|
Jun 03, 2024 |
|
S1 Ep111: Ensuring Quality Rectal Cancer Surgery at NAPRC-Accredited Institutions
|
May 27, 2024 |
|
S1 Ep110: Finding a Place for Exercise Oncology in the Treatment of Breast Cancer
|
May 20, 2024 |
|
S1 Ep109: Leveraging Surgical Oncology Advances in Colorectal Cancer Care
|
May 13, 2024 |
|
S1 Ep108: Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
|
May 06, 2024 |
|
S1 Ep107: Applying Novel Radiotherapy Technology for Brain Tumors and Other Cancers
|
Apr 29, 2024 |
|
S1 Ep106: Moving The Needle in Lung Cancer Management With Robotic-Assisted Surgery
|
Apr 22, 2024 |
|
S1 Ep105: Surgeons Talk Key Treatment and Institutional Advances Across Oncology Care
|
Apr 15, 2024 |
|
S1 Ep104: Finding Ways to Break the Mold in GU Oncology
|
Apr 08, 2024 |
|
S1 Ep103: Achieving Health Equity in Lung Cancer Surgery
|
Apr 01, 2024 |
|
S1 Ep102: Updated ASCO Guidelines for Optimal Small Cell Lung Cancer Management
|
Mar 25, 2024 |
|
S1 Ep101: Creating a First-of-Its-Kind Integrative Oncology Program at City of Hope
|
Mar 18, 2024 |
|
S1 Ep100: Addressing Rising Cancer Incidence and Burden in Younger Populations
|
Mar 11, 2024 |
|
S1 Ep99: How to Expand Health Equity in Oncology
|
Mar 04, 2024 |
|
S1 Ep98: Diane M. Simeone, MD “Thrilled” To Be UCSD Moores Cancer Center Director
|
Feb 26, 2024 |
|
S1 Ep97: Expert Perspectives on 2024 ASCO GI Cancers Symposium Trial Updates
|
Feb 19, 2024 |
|
S1 Ep96: Combatting Stigmatization to Increase Lung Cancer Screening Access
|
Feb 12, 2024 |
|
S1 Ep95: Unraveling Resistance and Heterogeneity in Mantle Cell Lymphoma Management
|
Feb 05, 2024 |
|
S1 Ep94: SIO/ASCO Guidelines for Integrative Therapies to Manage Anxiety/Depression
|
Jan 29, 2024 |
|
S1 Ep93: Jyoti S. Mayadev, MD, on Pembrolizumab/CRT FDA Approval in Cervical Cancer
|
Jan 22, 2024 |
|
S1 Ep92: Managing CDK4/6 Inhibitor, ADC Toxicity in Metastatic Breast Cancer
|
Jan 15, 2024 |
|
S1 Ep91: HER2CLIMB-02 Trial Shows ‘Interesting Data’ in HER2+ Breast Cancer
|
Jan 09, 2024 |
|
S1 Ep90: Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
|
Jan 01, 2024 |
|
S1 Ep89: Expert Discusses Screening Advocacy, AI, and Developments in Breast Cancer
|
Dec 18, 2023 |
|
S1 Ep88: Joleen Hubbard, MD, Highlights The “Exciting Space” Of Metastatic CRC
|
Dec 11, 2023 |
|
S1 Ep87: Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery
|
Dec 04, 2023 |
|
S1 Ep86: Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment
|
Nov 27, 2023 |
|
S1 Ep85: Multidisciplinary Care and New Treatment Options in CRC
|
Nov 20, 2023 |
|
S1 Ep84: Multidisciplinary Care, Approval Updates, and Future Research in NSCLC
|
Nov 13, 2023 |
|
S1 Ep83: Psychosocial Approach to Sexual Dysfunction During and After Cancer Treatment
|
Nov 08, 2023 |
|
S1 Ep82: Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer
|
Oct 30, 2023 |
|
S1 Ep81: Pipeline Perspectives: Fruquintinib in Metastatic Colorectal Cancer
|
Oct 02, 2023 |
|
S1 Ep80: Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances
|
Sep 11, 2023 |
|
S1 Ep79: Frontline Forum: Testing and Targeted Therapy in EGFR Exon20+ NSCLC
|
Sep 04, 2023 |
|
S1 Ep78: Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma
|
Aug 14, 2023 |
|
S1 Ep77: Relapsed/Refractory Multiple Myeloma Trial Updates From ASCO 2023
|
Aug 07, 2023 |
|
S1 Ep76: Sarcoma Awareness Month 2023 with Brian Van Tine, MD, PhD
|
Jul 31, 2023 |
|
S1 Ep75: Oncology On-The-Go Podcast: Secondary Cancer Susceptibility in Cancer Survivors
|
Jun 27, 2023 |
|
S1 Ep74: Oncology On-The-Go Podcast: ASCO 2023 Recap
|
Jun 19, 2023 |
|
S1 Ep73: Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer
|
May 15, 2023 |
|
S1 Ep72: Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
|
May 08, 2023 |
|
S1 Ep71: Oncology-On-The-Go Podcast: Signaling Pathways in Glioblastoma Relapse
|
May 01, 2023 |
|
S1 Ep70: Oncology On-The-Go Podcast: SGO 2023 Recap
|
Apr 24, 2023 |
|
S1 Ep69: Oncology On-The-Go Podcast: COVID-19 Vaccination and Cellular Therapy in Cancer
|
Apr 17, 2023 |
|
S1 Ep68: Oncology On-The-Go Podcast: Multiple Myeloma Outcome Disparities, Trial Access
|
Apr 12, 2023 |
|
S1 Ep67: Oncology On-The-Go Podcast: Integrative and Palliative Kidney Cancer Care
|
Mar 28, 2023 |
|
S1 Ep66: Oncology On-The-Go Podcast: Time to Treatment for Breast Cancer in Rural Populations
|
Feb 27, 2023 |
|
S1 Ep65: Oncology On-the-Go Podcast: Sacituzumab Govitecan for HR+/HER2– Advanced Breast Cancer
|
Feb 20, 2023 |
|
S1 Ep64: Oncology Peer Review On-The-Go Podcast: Cervical Cancer Screenings/Survival in Those 65+ Years
|
Feb 02, 2023 |
|
S1 Ep63: Oncology Peer Review On-The-Go: Integrative Oncology in Young Population with Breast Cancer
|
Jan 16, 2023 |
|
S1 Ep62: Oncology Peer Review On-The-Go: Experts Share Multidisciplinary Takeaways From 2022 SABCS
|
Dec 26, 2022 |
|
S1 Ep61: Oncology Peer Review On-The-Go: Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer
|
Nov 14, 2022 |
|
S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma
|
Nov 03, 2022 |
|
S1 Ep60: Oncology Peer Review On-The-Go: Cancer Pain and Opioid Use Disorder
|
Oct 31, 2022 |
|
S1 Ep59: Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology
|
Sep 19, 2022 |
|
S1 Ep58: Oncology Peer Review On-The-Go: Current Treatments in Peripheral T-cell Lymphoma
|
Aug 22, 2022 |
|
S1 Ep56: Oncology Peer Review On-The-Go: Current Treatments in Marginal Zone Lymphoma
|
Aug 09, 2022 |
|
S1 Ep55: Oncology Peer Review On-The-Go: The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study
|
Jul 25, 2022 |
|
S1 Ep54: Oncology Peer Review On-The-Go: Focus of Current and Emerging Therapies in Follicular Lymphoma
|
Jul 11, 2022 |
|
S1 Ep57: Oncology Peer Review On-The-Go: Paolo Tarantino, MD, and Sara Tolaney, MD, Review Data in the Treatment of Breast Cancer at 2022 ASCO
|
Jun 30, 2022 |
|
S1 Ep52: Oncology Peer Review On-The-Go: Financial Conflicts of Interest Among Junior Faculty in Hematology and Oncology
|
Jun 27, 2022 |
|
S1 Ep51: Oncology Peer Review On-The-Go: Academic Promotion and Oncology Drug Development
|
Jun 20, 2022 |
|
S1 Ep25: Oncology Peer Review On-The-Go: Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIs
|
May 30, 2022 |
|
S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma
|
May 20, 2022 |
|
S1 Ep49: Tanios Bekaii-Saab, MD, and Colleagues Discuss GOZILA Platform for CRC
|
May 16, 2022 |
|
S1 Ep50: Tanios Bekaii-Saab, MD, and Experts Examine Therapy Resistance in CRC
|
May 16, 2022 |
|
S1 Ep48: Tanios Bekaii-Saab, MD, Talks COLOMATE Platform for CRC With GI Experts
|
May 09, 2022 |
|
S2 Ep24: OncView™ Podcast: Advances in Systemic Therapy of Differentiated Thyroid Cancer
|
May 06, 2022 |
|
S2 Ep23: OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC
|
Apr 29, 2022 |
|
S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC
|
Apr 27, 2022 |
|
S1 Ep47: Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma
|
Apr 25, 2022 |
|
S1 Ep46: PARP Inhibitors as Maintenance Therapy for Metastatic CRPC
|
Apr 11, 2022 |
|
S2 Ep21: OncView™ Podcast: EGFR Exon 20 Insertion as Therapeutic Target in NSCLC
|
Apr 08, 2022 |
|
S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer
|
Apr 05, 2022 |
|
S2 Ep19: OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
|
Apr 02, 2022 |
|
S2 Ep18: OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer
|
Mar 30, 2022 |
|
S1 Ep45: Real-World Assessment of Care and Efficiency With Subcutaneous Rituximab
|
Mar 28, 2022 |
|
S1 Ep44: Neoadjuvant Chemotherapy for Elderly Patients with Muscle-Invasive Bladder Cancer
|
Mar 14, 2022 |
|
S1 Ep43: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial
|
Feb 28, 2022 |
|
S1 Ep42: Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma
|
Feb 14, 2022 |
|
S1 Ep41: Matthew Allaway, DO, on Transperineal Biopsy Approach for Prostate Cancer
|
Jan 31, 2022 |
|
S1 Ep40: Amy Comander, MD, on SABCS and Key Breast Cancer Data from 2021
|
Jan 17, 2022 |
|
S2 Ep17: Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC
|
Jan 14, 2022 |
|
S1 Ep39: Improving Experience of LGBTQ+ Patients in Cancer Care
|
Jan 03, 2022 |
|
S2 Ep16: Future Directions in Small Cell Lung Cancer Treatment
|
Dec 22, 2021 |
|
S1 Ep38: Relationship Between Medical Oncologists and Genetic Counselors in Prostate Cancer
|
Dec 20, 2021 |
|
S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options
|
Dec 16, 2021 |
|
S1 Ep37: Increasing Testing Access and Guiding Treatment Options with TrialJectory
|
Dec 06, 2021 |
|
S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer
|
Dec 02, 2021 |
|
S1 Ep36: Value of Geriatric Assessment in Patients With Genitourinary Carcinoma
|
Nov 22, 2021 |
|
S1 Ep35: Germline Testing in Prostate Cancer: When and Who to Test
|
Nov 08, 2021 |
|
S2 Ep13: First-Line Therapeutic Options in Small Cell Lung Cancer
|
Nov 01, 2021 |
|
S2 Ep12: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates
|
Oct 29, 2021 |
|
S1 Ep34: Debra Patt, MD, PhD, MBA, FASCO, on Telehealth in Cancer Care
|
Oct 25, 2021 |
|
S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer
|
Oct 19, 2021 |
|
S1 Ep33: Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer
|
Oct 11, 2021 |
|
S1 Ep32: ScaleReady’s Work to Make Cell and Gene Therapy Practical and Viable
|
Sep 27, 2021 |
|
S1 Ep31: Inside the Advancing Inclusive Research Site Alliance for Clinical Trial Diversity
|
Sep 13, 2021 |
|
S2 Ep10: Two Experts Review Important R/R DLBCL Treatment Decisions and Data
|
Aug 30, 2021 |
|
S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma
|
Aug 25, 2021 |
|
S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer
|
Aug 20, 2021 |
|
S1 Ep30: Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years
|
Aug 16, 2021 |
|
S1 Ep29: Examining Evidence Underlying the NCCN Guidelines for Hematologic Malignancies
|
Aug 02, 2021 |
|
S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL
|
Jul 30, 2021 |
|
S1 Ep28: Considering Second-Line Treatment Amidst Evolving Frontline Landscape for Clear Cell RCC
|
Jul 19, 2021 |
|
S2 Ep6: OncView™ Podcast: Updates in Managing Extensive-Stage Small Cell Lung Cancer
|
Jul 16, 2021 |
|
S1 Ep27: BPCIA, 4-Letter Suffix Rule, & the Challenges of Biosimilar Prescription
|
Jul 05, 2021 |
|
S2 Ep5: Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCL
|
Jun 30, 2021 |
|
S2 Ep4: OncView Podcast: Front-Line Management of Extensive-Stage SCLC
|
Jun 28, 2021 |
|
S1 Ep26: Molecular Profiling Practices in Pancreatic Adenocarcinoma
|
Jun 21, 2021 |
|
S2 Ep3: OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma
|
Jun 17, 2021 |
|
S1 Ep25: Primary Focal Therapy for Localized Prostate Cancer
|
Jun 07, 2021 |
|
S1 Ep24: Treatment Considerations for Transplant-Ineligible Multiple Myeloma
|
May 24, 2021 |
|
S2 Ep2: OncView Podcast: Optimizing Treatment With Extended Adjuvant Therapy for HR+ Breast Cancer
|
May 19, 2021 |
|
S2 Ep1: OncView Podcast: Genomic Testing in HR+ Breast Cancer to Guide Therapy in the Extended Adjuvant Setting
|
May 18, 2021 |
|
S1 Ep23: A Critical Interval to Delay Progression of Prostate Cancer
|
May 10, 2021 |
|
S1 Ep22: Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics
|
Apr 26, 2021 |
|
S1 Ep21: 1-on-1 with David Johnson: Enveric's Endocannabinoid Products for Glioblastoma
|
Apr 12, 2021 |
|
S1 Ep20: COVID-19, Cancer, and the Potential of mRNA Vaccines
|
Mar 29, 2021 |
|
S1 Ep19: Impact of Treatment Refusal on Survival for Small Cell Lung Cancer
|
Mar 15, 2021 |
|
S1 Ep18: 1-on-1 with Richard Schilsky, MD: Molecular Profiling in GI Cancers
|
Mar 01, 2021 |
|
S1 Ep17: Utility of 21-Gene Recurrence Score for Node-Positive Breast Cancer
|
Feb 15, 2021 |
|
S1 Ep16: Mediterranean Diet's Association with Localized Prostate Cancer
|
Feb 01, 2021 |
|
S1 Ep15: Guidelines for Palliative Treatment of Spinal Metastases
|
Jan 18, 2021 |
|
S1 Ep14: 1-on-1 with Che-Kai Tsao, MD: Smoking Cessation and Patient Screening
|
Jan 04, 2021 |
|
S1 Ep13: Recommending Patient-Reported Outcomes of Pain for Cancer Care
|
Dec 21, 2020 |
|
S1 Ep12: 1-on-1 with Zuri Murrell, MD: Colorectal Cancer in Black Patients
|
Dec 07, 2020 |
|
S1 Ep11: Fertility Preservation Decision-Making for Adolescents with Cancer
|
Nov 23, 2020 |
|
S1 Ep10: Barriers to Pancreatic Cancer Clinical Trial Enrollment
|
Nov 09, 2020 |
|
S1 Ep9: Cancer Care Management During the COVID-19 Pandemic
|
Oct 26, 2020 |
|
S1 Ep8: The Psychological Aspect of Patients in Phase 1 Clinical Trials
|
Oct 12, 2020 |
|
S1 Ep7: Molecular Profiling in Metastatic Colorectal Cancer
|
Sep 28, 2020 |
|
S1 Ep6: 1-on-1 with Dr. Michael Randell: New ACS Guidelines for Cervical Cancer
|
Sep 14, 2020 |
|
S1 Ep5: Is Next-Generation Sequencing a Right for Patients with GI Cancers?
|
Aug 31, 2020 |
|
S1 Ep4: The COVID-19 Pandemic's Impact on Cancer Screenings
|
Aug 17, 2020 |
|
S1 Ep3: Clinical Trials System and the COVID-19 Pandemic
|
Aug 03, 2020 |
|
S1 Ep2: 1-on-1 with Dr. Xu Ji: Mental Health Among Cancer Survivors
|
Jul 20, 2020 |
|
S1 Ep1: Minority Treatment Disparities and Clinical Trial Enrollment
|
Jul 06, 2020 |